$0.302700
-0.0008-0.26%
Pre-Market: 7:42 AM EDT
15 minutes delayed
Comments
Loading...
TransCode Therapeutics
RNAZNASDAQ
TransCode Therapeutics (RNAZ) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
TransCode Therapeutics (NASDAQ:RNAZ) Stock Quotes, Forecast and News Summary
TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 74.89K / 1.40M |
| Day Range | - - - |
| 52 Wk Range | 0.29 - 128.00 |
| Market Cap | $2.20M |
| P/E Ratio | 0.00 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 27 |
| Short Interest | 2.3% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About TransCode Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disea...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy TransCode Therapeutics (RNAZ) stock?
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Who are TransCode Therapeutics (RNAZ) competitors?
Other companies in TransCode Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO) and Bone Biologics (NASDAQ:BBLG).
What is the target price for TransCode Therapeutics (RNAZ) stock?
There is no analysis for TransCode Therapeutics.
What is the forecast for TransCode Therapeutics (RNAZ) stock?
TransCode Therapeutics has a consensus price target of $3.00.
Current stock price for TransCode Therapeutics (RNAZ)?
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.3027 last updated Today at July 24, 2024 at 7:42 AM EDT.
Does TransCode Therapeutics (RNAZ) pay a dividend?
There are no upcoming dividends for TransCode Therapeutics.
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
TransCode Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is TransCode Therapeutics (RNAZ) going to split?
There is no upcoming split for TransCode Therapeutics.
What sector and industry does TransCode Therapeutics (RNAZ) operate in?
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.